PAG
SLS icon

Private Advisor Group’s SELLAS Life Sciences SLS Stock Holding History

Private Advisor Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Sell
15,650
-3,890
-20% -$26.9K ﹤0.01% 2269
2026
Q1 		$82.7K Buy
19,540
+1,335
+7% +$5.97K ﹤0.01% 2545
2025
Q4 		$68.6K Buy
+18,205
New +$35.4K ﹤0.01% 2503

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Private Advisor Group's SLS Position: Q2 2026 in Review

Private Advisor Group reduced its SELLAS Life Sciences (SLS) stake by 20% in Q2 2026, selling an estimated $26.9K and leaving 15,650 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Private Advisor Group first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Private Advisor Group held 15,650 shares of SELLAS Life Sciences worth $231K as of Q2 2026.
  • Private Advisor Group sold 3,890 SELLAS Life Sciences shares in Q2 2026, an estimated $26.9K.
  • SELLAS Life Sciences made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2269 holding.
  • Private Advisor Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.